MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks
NCT03824717
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Infraclavicular Brachial Plexus Block
Interventions
DRUG:
Dose of ropivacaine
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's